Loading clinical trials...
Loading clinical trials...
Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or disseminated form can occur. The etiology of granuloma annulare is unknown, however, multiple inciting factors have been proposed. The purpose of the investigators is to review the outcomes of treatment of granuloma annulare (GA) resistant to standard regimens that resolved after a 3-months treatment course of monthly rifampin, ofloxacin, and minocycline (ROM) therapy, successfully used to treat paucibacillary leprosy, a disease with clinical and histopathologic similarity to GA.
We will document the regimen treatment each patient has had and then review the following from the patient's chart to target our specific aims as outlined above. 1. What previous treatment options have been or/are currently being used? 2. How long did the patient take the treatment for? 3. Was the patient able to discontinue or become less dependent on prior treatment? 4. Was the disease process slowed by the treatment?; 5. Were there any side effects that the patient experienced with treatment?
Age
All ages
Sex
ALL
Healthy Volunteers
No
Henry Ford Medical Center
Detroit, Michigan, United States
Start Date
May 1, 2008
Primary Completion Date
May 1, 2008
Completion Date
July 1, 2008
Last Updated
April 30, 2024
6
ACTUAL participants
Lead Sponsor
Henry Ford Health System
NCT03910543
NCT00129428
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions